Cosmo Pharmaceuticals N.V Cash Flow Reinvestment Rate
Cosmo Pharmaceuticals N.V cash flow reinvestment rate. Cosmo Pharmaceuticals N.V (C43) has a Cash Flow Reinvestment Rate of 3.04x as of June 2022, reinvesting €19.08 Million (capex €1.11 Million plus investments €17.98 Million) from operating cash flow of €6.28 Million. Explore how well can Cosmo Pharmaceuticals N.V service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Cosmo Pharmaceuticals N.V (2016–2024)
Cash flow reinvestment rate of Cosmo Pharmaceuticals N.V from 2016 to 2024. Historical reinvestment intensity for Cosmo Pharmaceuticals N.V across 6 annual periods. Explore Cosmo Pharmaceuticals N.V capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Cosmo Pharmaceuticals N.V Cash Flow Reinvestment Rate by Year (2016–2024)
Cosmo Pharmaceuticals N.V cash flow reinvestment rate by year from 2016 to 2024. Year-by-year capital reinvestment analysis for Cosmo Pharmaceuticals N.V. For the full cash flow conversion analysis, see cash flow conversion of Cosmo Pharmaceuticals N.V.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.79x | €129.11 Million | €162.41 Million | €5.65 Million | ▼ -53.6% |
| 2023 | 1.71x | €57.61 Million | €33.62 Million | €15.31 Million | ▲ +532.7% |
| 2022 | 0.27x | €9.00 Million | €33.23 Million | €7.31 Million | ▼ -72.1% |
| 2021 | 0.97x | €12.22 Million | €12.61 Million | €5.49 Million | ▼ -88.7% |
| 2020 | 8.59x | €111.60 Million | €12.98 Million | €4.12 Million | ▲ +217.9% |
| 2016 | 2.70x | €58.65 Million | €21.69 Million | €18.43 Million | — |